TickerFacts.

Company research / SKIN

SkinHealth Systems Inc. (SKIN)

Build a valuation ↗↓ Download CSV

CIK 0001818093 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, SkinHealth Systems Inc. reported revenue of $300.79M. Revenue fell 10.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $290.05M.

Key ratios (year ended 2025-12-31)

65.3%
Gross margin
-6.9%
Operating margin
-3.2%
Net margin
-15.6%
Return on year-end equity
-10.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$290.05M$300.79M$334.29M$397.99M$365.88M$260.09M$119.09M$166.62M
Cost of Revenue$97.60M$104.43M$152.00M$242.88M$117.10M$81.55M$51.89M$60.11M
Gross Profit$192.45M$196.36M$182.30M$155.11M$248.78M$178.54M$67.20M$106.51M
R&D Expense$5.89M$5.63M$6.30M$10.10M$8.44M$8.20M$3.41M$4.61M
Operating Income-$4.31M-$20.80M-$67.77M-$130.92M-$25.84M-$39.93M-$17.18M$13.46M
Net Income-$28.43M-$9.52M-$29.10M-$100.12M$44.22M-$378.76M-$29.18M-$1.64M
EPS (Diluted)n/a-$0.16-$0.36-$0.76-$0.23-$3.71-$0.85-$0.05
Total Assets$486.57M$499.80M$685.68M$929.11M$1.00B$1.22B$222.84Mn/a
Total Liabilities$431.00M$438.75M$633.88M$869.72M$836.03M$916.51M$252.79Mn/a
Shareholders' Equity$55.57M$61.06M$51.80M$59.39M$167.05M$298.03M-$29.96M-$1.21M
Cash & Equivalentsn/an/an/a$523.02M$568.20M$901.89M$9.49Mn/a
Operating Cash Flow$21.96M$37.48M$16.13M$21.75M-$106.60M-$28.36M-$12.44M$1.73M
Capital Expenditures$817.0K$303.0K$756.0K$3.83M$10.85M$11.20M$3.50M$8.77M
Free Cash Flow$21.14M$37.18M$15.38M$17.93M-$117.45M-$39.56M-$15.94M-$7.05M
Share Repurchasesn/a$0$0$30.16M$160.00M$0$154.0K$0
Shares Outstanding130.10M127.52M124.92M122.90M132.21M150.60M35.50M32.14M
Weighted Average Diluted Sharesn/a135.80M142.49M131.68M148.51M102.11M34.29M32.14M
EPS (Basic)n/a-$0.08-$0.23-$0.76$0.30-$3.71-$0.85-$0.05

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView